A

AstraZeneca

Global pharmaceutical company developing prescription medicines

Associate Director - Global Analytical Lifecycle Management

Regulatory & Quality (Life Sciences)Posted on Nov 13
Full-time

About the Job

Requirements

  • A BS in analytical sciences, biotechnology, biochemistry, cell or molecular biology, pharmaceutical sciences, engineering, or a related discipline with 10 or more years of experience; an MS in those fields with 5 or more years of experience; or a PhD in those fields with 3 or more years of experience.
  • Significant progressive biopharmaceutical industry experience, including cell therapy, gene therapy, or other advanced therapy medicinal products.
  • Demonstrated experience leading analytical lifecycle activities for late-stage, pivotal, PPQ, commercial, or post-approval programs.
  • Strong technical expertise in cell therapy analytical methods, including cell-based potency assays, flow cytometry, molecular assays such as qPCR and dPCR, identity, purity, safety, residuals, and microbiological release testing.
  • Experience defining and overseeing method validation, transfer, comparability, bridging, controlled method change, and continued performance monitoring in a GMP environment.
  • Experience authoring or providing technical oversight of analytical CMC regulatory content, including IND/IMPD, BLA/MAA, variations, supplements, and responses to health authority questions.
  • Working knowledge of GMP, data integrity, quality risk management, investigations, change control, CAPA, and inspection readiness.
  • Working knowledge of ICH Q2(R2), ICH Q14, and analytical lifecycle management principles.
  • Ability to lead complex cross-functional technical workstreams, influence without direct authority in a matrix organization, and communicate risks and recommendations clearly to senior stakeholders.
  • Technical writing, data interpretation, and presentation skills.

Responsibilities

  • Own product-level analytical lifecycle strategy and network-level governance standards for late-stage and commercial cell therapy products, aligned to control strategy and program milestones; define risk-based plans for transfer, validation, continued performance verification, and critical reagent and reference standard lifecycle.
  • Define and govern analytical lifecycle handover from Analytical Development to QC, including transfer-package expectations, readiness criteria, decision points, and evidence that methods are fit for intended use across the testing network.
  • Assess analytical impact of process, material, equipment, method, or site changes; set product-level change control strategy, including bridging, comparability, validation, and post-change monitoring with Regulatory and Quality.
  • Define method transfer and validation strategies across internal and external networks; provide scientific oversight of protocols, reports, and statistics aligned with GMP and ICH Q2(R2)/Q14; lead comparability and revalidation strategies for method and platform changes and multi-site implementation.
  • Define network method-performance monitoring and assess cross-site trends, drift, and lifecycle risks.
  • Provide analytical lifecycle content and technical review for regulatory submissions, variations, supplements, and responses to health authority questions; serve as the analytical lifecycle subject matter expert during inspections and audits with Regulatory CMC and Quality.
  • Define and govern analytical readiness requirements for PPQ, launch, and testing-network expansion, including QC readiness criteria, escalation pathways, and continuity strategies for critical reagents, reference standards, testing capacity, and alternate-site capability.
  • Represent analytical lifecycle on product and CMC teams; lead governance forums to frame decisions and escalate risks; drive continuous improvement and harmonization of global analytical lifecycle processes and technical guidelines to strengthen method robustness and scalability across cell therapy modalities.

Desired Qualifications

  • Direct experience with CAR-T, autologous or allogeneic cell therapy, lentiviral vector, in vivo gene therapy, or gene-editing products.
  • Experience supporting commercial launch, commercial-site introduction, or post-approval analytical change programs.
  • Experience with multi-site QC networks, contract testing laboratories, CDMOs, or global external partner models.
  • Experience with critical reagent and reference standard qualification, bridging, and lifecycle management.
  • Applied statistical expertise in continued performance verification, equivalence testing, and comparability assessment.
  • Direct participation in pre-approval inspections, health authority meetings, or formal regulatory responses.
  • Experience implementing controlled digital analytical tools, data-analysis templates, laboratory information systems, or analytical automation.
  • Demonstrated mentoring, coaching, or matrix technical leadership experience.

About the Company

AstraZeneca

Global pharmaceutical company developing prescription medicines

AstraZeneca develops and markets prescription medicines and vaccines worldwide, with a focus on oncology, cardiovascular/metabolic, respiratory, and infectious diseases. Its products work by targeting specific biological pathways or cells, using small-molecule therapies, biologics, and vaccines to treat diseases or prevent infections. It differentiates itself through its dual heritage from Sweden and the UK, a broad pipeline, and strong R&D and collaborations that move from discovery to patient access. Its goal is to improve people’s health by discovering, developing, and delivering medicines and vaccines to patients worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913

Recently Posted Jobs

Explore more opportunities at AstraZeneca

See more jobs